Svmuu News Nasdaq Listed company Canton Strategic Holdings announced that the sale of its biotechnology R&D division, Gravitas Life Sciences, has been completed. The buyer in this transaction was Gravitas Collective Corp. The deal was unanimously approved by the company’s board of directors and officially closed on July 17, 2026.
This divestiture represents a key strategic transformation for the company. Moving forward, the company will focus on the Canton Network ecosystem, transitioning into a digital service provider for financial markets. It will prioritize the implementation of asset tokenization and financial digitization while continuing to enhance its compliant financial infrastructure business. (PRNewswire)
Canton Strategic Sells Biotechnology Subsidiary Gravitas to Focus on Digital Finance
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Samsung Electronics is down 4.44% from its previous close, now trading at ₩231,250.
-
2
Samsung Electronics fell 5.99% from its previous close, now trading at ₩227,500.
-
3
Former Aptos advisor "Buzz" leaves project, shifts meme marketing efforts to Meta stock
-
4
Global Mainstream Cryptocurrency Exchange Landscape and Characteristics Analysis
-
5
President Trump returns to Ohio, highlighting over $100 billion in private investment attracted to the state during his term.
-
6
Global Major Cryptocurrency Exchange Rankings and Key Factors for Platform Selection
-
7
Nikkei Asia: Iranian separatists intensify attacks and seize territory in response to a potential full-scale US assault.
-
8
FOR Token (ForTube) Issuance Price and Project Analysis
-
9
A Boston office building was sold at a foreclosure auction for one-third of its 2019 price, representing a discount of approximately $546 million.
-
10
Bybit will delist the PTBUSDT Perpetual Contract at 9:00 AM UTC on October 30.
Markets Today
Recommended Reading




